346 related articles for article (PubMed ID: 23879434)
1. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature.
Pijls KE; Jonkers DM; Elamin EE; Masclee AA; Koek GH
Liver Int; 2013 Nov; 33(10):1457-69. PubMed ID: 23879434
[TBL] [Abstract][Full Text] [Related]
2. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
3. Could antioxidants be the "magic pill" for cirrhosis-related complications? A pathophysiological appraisal.
Assimakopoulos SF; Gogos C; Labropoulou-Karatza C
Med Hypotheses; 2011 Sep; 77(3):419-23. PubMed ID: 21703771
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-related complications in cirrhosis.
Gómez-Hurtado I; Such J; Sanz Y; Francés R
World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and probiotics in chronic liver diseases.
Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
[TBL] [Abstract][Full Text] [Related]
6. Large intestine permeability is increased in patients with compensated liver cirrhosis.
Pijls KE; Koek GH; Elamin EE; de Vries H; Masclee AA; Jonkers DM
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(2):G147-53. PubMed ID: 24264047
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
Lorenzo-Zúñiga V; Rodríguez-Ortigosa CM; Bartolí R; Martínez-Chantar ML; Martínez-Peralta L; Pardo A; Ojanguren I; Quiroga J; Planas R; Prieto J
Gut; 2006 Sep; 55(9):1306-12. PubMed ID: 16434425
[TBL] [Abstract][Full Text] [Related]
8. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
[TBL] [Abstract][Full Text] [Related]
9. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.
Bellot P; Francés R; Such J
Liver Int; 2013 Jan; 33(1):31-9. PubMed ID: 23121656
[TBL] [Abstract][Full Text] [Related]
10. Gut-liver axis signaling in portal hypertension.
Simbrunner B; Mandorfer M; Trauner M; Reiberger T
World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
[TBL] [Abstract][Full Text] [Related]
11. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.
Assimakopoulos SF; Tsamandas AC; Tsiaoussis GI; Karatza E; Triantos C; Vagianos CE; Spiliopoulou I; Kaltezioti V; Charonis A; Nikolopoulou VN; Scopa CD; Thomopoulos KC
Eur J Clin Invest; 2012 Apr; 42(4):439-46. PubMed ID: 22023490
[TBL] [Abstract][Full Text] [Related]
12. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
[TBL] [Abstract][Full Text] [Related]
13. The role of FoxO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injury.
Chang B; Sang L; Wang Y; Tong J; Wang B
Int J Mol Med; 2013 Mar; 31(3):569-76. PubMed ID: 23292333
[TBL] [Abstract][Full Text] [Related]
14. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta.
Wu LL; Chiu HD; Peng WH; Lin BR; Lu KS; Lu YZ; Yu LC
Crit Care Med; 2011 Sep; 39(9):2087-98. PubMed ID: 21552122
[TBL] [Abstract][Full Text] [Related]
15. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.
Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A
World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676
[TBL] [Abstract][Full Text] [Related]
16. [Intervention of microecological preparation in the changes of intestinal barrier in cirrhosis].
Zhang ST; Zhao HY
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(39):2742-3. PubMed ID: 16324311
[No Abstract] [Full Text] [Related]
17. Gastrointestinal tract in liver disease: which organ is sick?
Norman K; Pirlich M
Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):613-9. PubMed ID: 18685458
[TBL] [Abstract][Full Text] [Related]
18. Methods to determine intestinal permeability and bacterial translocation during liver disease.
Wang L; Llorente C; Hartmann P; Yang AM; Chen P; Schnabl B
J Immunol Methods; 2015 Jun; 421():44-53. PubMed ID: 25595554
[TBL] [Abstract][Full Text] [Related]
19. Potential mechanisms linking gut microbiota and portal hypertension.
Baffy G
Liver Int; 2019 Apr; 39(4):598-609. PubMed ID: 30312513
[TBL] [Abstract][Full Text] [Related]
20. Bacterial translocation: overview of mechanisms and clinical impact.
Balzan S; de Almeida Quadros C; de Cleva R; Zilberstein B; Cecconello I
J Gastroenterol Hepatol; 2007 Apr; 22(4):464-71. PubMed ID: 17376034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
